Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 8:02 pm Purchase |
2024-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
Redmile Group LLC | 13,932,449 9.900% |
10,155,602 (+268.89%) |
Filing History |
| 2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
ORBIMED ADVISORS LLC | 13,135,260 9.900% |
13,135,260 (New Position) |
Filing History |
| 2025-02-14 4:15 pm Purchase |
2024-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
PERCEPTIVE ADVISORS LLC | 5,880,000 4.500% |
3,740,050 (+174.77%) |
Filing History |
| 2025-02-07 5:31 pm Sale |
2025-01-31 | 13G | RAPT Therapeutics, Inc. RAPT |
The Vanguard Group | 2,932,399 2.220% |
-223,606 (-7.09%) |
Filing History |
| 2025-02-07 5:31 pm Sale |
2025-01-31 | 13G | RAPT Therapeutics, Inc. RAPT |
The Vanguard Group | 2,932,399 2.220% |
-223,606 (-7.09%) |
Filing History |
| 2025-02-07 10:23 am Sale |
2025-01-31 | 13G | RAPT Therapeutics, Inc. RAPT |
FMR CORP | 480,507 0.400% |
-4,755,014 (-90.82%) |
Filing History |
| 2025-01-06 6:38 pm Purchase |
2024-12-27 | 13G | RAPT Therapeutics, Inc. RAPT |
BIOTECHNOLOGY VALUE FUND L P | 11,764,000 8.700% |
11,764,000 (New Position) |
Filing History |
| 2025-01-06 09:22 am Purchase |
2024-12-27 | 13G | RAPT Therapeutics, Inc. RAPT |
Medicxi IV LP | 22,352,000 16.900% |
22,352,000 (New Position) |
Filing History |
| 2025-01-03 4:08 pm Purchase |
2024-12-27 | 13G | RAPT Therapeutics, Inc. RAPT |
TCG Crossover GP II, LLC | 13,193,110 9.990% |
13,193,110 (New Position) |
Filing History |
| 2024-12-30 3:32 pm Purchase |
2024-12-23 | 13G | RAPT Therapeutics, Inc. RAPT |
Foresite Capital Fund VI, L.P. | 12,500,000 9.300% |
12,500,000 (New Position) |
Filing History |
| 2024-12-23 8:20 pm Sale |
2024-12-23 | 13D | RAPT Therapeutics, Inc. RAPT |
The Column Group II, LP | 1,603,593 4.900% |
-2,821,846 (-63.76%) |
Filing History |
| 2024-12-23 4:42 pm Purchase |
2024-12-23 | 13G | RAPT Therapeutics, Inc. RAPT |
Deep Track Capital, LP | 14,116,000 9.870% |
14,116,000 (New Position) |
Filing History |
| 2024-11-14 1:22 pm Sale |
2024-09-30 | 13G | RAPT Therapeutics, Inc. RAPT |
PRICE T ROWE ASSOCIATES INC | 175,776 0.500% |
-3,237,776 (-94.85%) |
Filing History |
| 2024-11-14 09:39 am Sale |
2024-09-30 | 13G | RAPT Therapeutics, Inc. RAPT |
Deep Track Capital, LP | 0 0.000% |
-1,793,966 (Position Closed) |
Filing History |
| 2024-11-12 4:59 pm Unchanged |
2024-09-30 | 13G | RAPT Therapeutics, Inc. RAPT |
The Vanguard Group | 3,156,005 9.040% |
0 (Unchanged) |
Filing History |
| 2024-11-12 10:34 am Purchase |
2024-11-08 | 13G | RAPT Therapeutics, Inc. RAPT |
FMR CORP | 5,235,521 14.999% |
1,392,134 (+36.22%) |
Filing History |
| 2024-11-04 1:30 pm Purchase |
2024-09-30 | 13G | RAPT Therapeutics, Inc. RAPT |
The Vanguard Group | 3,156,005 9.040% |
1,099,784 (+53.49%) |
Filing History |
| 2024-02-14 4:41 pm Purchase |
2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
PERCEPTIVE ADVISORS LLC | 2,139,950 6.200% |
340,995 (+18.96%) |
Filing History |
| 2024-02-14 4:26 pm Purchase |
2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
Redmile Group LLC | 3,776,847 9.900% |
97,009 (+2.64%) |
Filing History |
| 2024-02-14 10:03 am Sale |
2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
PRICE T ROWE ASSOCIATES INC | 3,413,552 9.900% |
-142,910 (-4.02%) |
Filing History |